• pspcx
• Mutual Fund
• US Stocks
• Large Blend

PIMCO StocksPLUS® Fund Class C

Expenses: 1.48% (Better than 0% of similar funds)

This is a bad choice for a Large Blend US Stocks fund. See why »

• arwax
• Mutual Fund
• Allocation
• Target-Date

American Century Investments One Choice 2025 Portfolio A Class

Expenses: 1.01% (Better than 0% of similar funds)

This is a bad choice for a Target-Date Allocation fund. See why »

• ipos
• ETF
• International Stocks
• Mid-Cap Growth

Renaissance International IPO ETF

Expenses: 0.80% (Better than 1% of similar funds)

This is a bad choice for a Mid-Cap Growth International Stocks fund. See why »

• jpc
• Mutual Fund
• Other
• Preferred Stock

Nuveen Preferred & Income Opportunities Fund

Expenses: 3.04% (Better than 0% of similar funds)

This is a bad choice for a Preferred Stock Other fund. See why »

• kio
• Mutual Fund
• Bond
• High Yield Bond

KKR Income Opportunities Fund

Expenses: 3.38% (Better than 0% of similar funds)

This is a bad choice for a High Yield Bond Bond fund. See why »

• jqc
• Mutual Fund
• Bond
• High Yield Bond

Nuveen Credit Strategies Income Fund

Expenses: 3.42% (Better than 0% of similar funds)

This is a bad choice for a High Yield Bond Bond fund. See why »

• jro
• Mutual Fund
• Bond
• High Yield Bond

Nuveen Floating Rate Income Opportunity Fund

Expenses: 3.31% (Better than 0% of similar funds)

This is a bad choice for a High Yield Bond Bond fund. See why »

• ftgtx
• Mutual Fund
• Allocation
• All-In-One

Franklin Growth Allocation Fund Class C

Expenses: 1.40% (Better than 0% of similar funds)

This is a bad choice for a All-In-One Allocation fund. See why »

• gpgox
• Mutual Fund
• Allocation
• Total World

Grandeur Peak Global Opportunities Fund Investor Class

Expenses: 1.57% (Better than 0% of similar funds)

This is a bad choice for a Total World Allocation fund. See why »

• phlax
• Mutual Fund
• Sector Equity
• Healthcare

PGIM Jennison Health Sciences Fund- Class A

Expenses: 1.15% (Better than 0% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »